G-CSFs are glycoproteins that stimulate the bone marrow to increase the production of neutrophils, a subclass of granulocytes. The most commonly used recombinant forms include filgrastim, pegfilgrastim, and lenograstim. These agents are used clinically to reduce the risk of infection in patients with compromised immune systems.
